March / April 2024
Features
What’s different (and not) about injecting GA drugs
Tips for injecting pegcetacoplan and avacincaptad pegol for geographic atrophy.
Update: Gene therapy clinical trials in neovascular age-related macular degeneration
Companies are attacking the disease from multiple angles.
.png)
How anti-VEGF biosimilars are changing retina care
Biosimilars are reducing costs and increasing access, but in retina they also face unique challenges compared with other medical specialties.
Pearls for the Port Delivery System with Ranibizumab refill-exchange procedure
This modality may help decrease the treatment burden.
Clinical primer on Eylea HD: Review of the current data
Here’s what we know about the new high-dose aflibercept based on the pivotal trials.
Departments
Editor's Page
News
North of the Border
Management options for PVR
What you need to know as a vitreoretinal surgeon.
Retina Rounds
Three strikes of inflammation
A case of Susac syndrome.
Social Media Specialist
What does it mean to be an influencer?
In today’s world, any retinal specialist can become an influencer.
Surgical Pearl Video
How to repair Eales’ disease TRD
Tips for surgical repair of a tractional retinal detachment with full-thickness macular hole secondary to a rare form of retinal vasculitis.
Current Issue
Continuing Medical Education
Additional Publications
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Sponsored by Regeneron
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
Improving Wet AMD Outcomes With a Fellow Eye Strategy
Eyepoint Yutiq: A Discussion Among Experts on the Treatment of Uveitis Affecting the Posterior Segment
